Clinical Trial

A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Evaluate the pharmacokinetic effects of itraconazole, fluconazole, or efavirenz on a single - dose of Clifutinib and the safety of the combination therapy in healthy participants.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-04-23 -> 2027-04-23 2026-04-28
minor Completion pushed: 2026-05-08 -> 2027-05-08 2026-04-28
Trial Details
NCT Number NCT07341672
Lead Sponsor Sunshine Lake Pharma Co., Ltd.
Conditions Healthy Adult Subject
Enrollment 80 participants
Start Date 2026-12-31
Primary Completion 2027-04-23 (estimated)
Study Completion 2027-05-08 (estimated)
Updated on ClinicalTrials.gov 2026-04-27